These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37865988)

  • 61. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.
    Jensen B; Chen J; Furnish T; Wallace M
    Curr Pain Headache Rep; 2015 Oct; 19(10):50. PubMed ID: 26325482
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of the Cannabinoid System in Alzheimer's Disease.
    Li S; Huang Y; Yu L; Ji X; Wu J
    Curr Neuropharmacol; 2023; 21(3):715-726. PubMed ID: 35105293
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
    Jacobson MR; Watts JJ; Boileau I; Tong J; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):330-348. PubMed ID: 30635160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies.
    Janero DR; Vadivel SK; Makriyannis A
    Int Rev Psychiatry; 2009 Apr; 21(2):122-33. PubMed ID: 19367506
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation.
    Osafo N; Yeboah OK; Antwi AO
    Mol Biol Rep; 2021 Apr; 48(4):3665-3680. PubMed ID: 33909195
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic potential of cannabinoids in schizophrenia.
    Kucerova J; Tabiova K; Drago F; Micale V
    Recent Pat CNS Drug Discov; 2014 Apr; 9(1):13-25. PubMed ID: 24605939
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microglial Cannabinoid CB
    Xu K; Wu Y; Tian Z; Xu Y; Wu C; Wang Z
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768668
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endocannabinoid mechanisms of pain modulation.
    Hohmann AG; Suplita RL
    AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endocannabinoids as Therapeutic Targets.
    Prospéro-García O; Ruiz Contreras AE; Ortega Gómez A; Herrera-Solís A; Méndez-Díaz M;
    Arch Med Res; 2019 Nov; 50(8):518-526. PubMed ID: 32028095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting the Endocannabinoid System in Psychiatric Illness.
    Katzman MA; Furtado M; Anand L
    J Clin Psychopharmacol; 2016 Dec; 36(6):691-703. PubMed ID: 27811555
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
    Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options.
    Lafreniere JD; Kelly MEM
    Neuronal Signal; 2018 Dec; 2(4):NS20170144. PubMed ID: 32714590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endocannabinoids.
    Suchopár Josef; Laštůvka Zdeněk; Mašková Simona; Alblová Miroslava; Pařízek Antonín
    Ceska Gynekol; 2021; 86(6):414-420. PubMed ID: 35038882
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder.
    Chu L; Shu Z; Gu X; Wu Y; Yang J; Deng H
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):445-463. PubMed ID: 36745405
    [No Abstract]   [Full Text] [Related]  

  • 76. Psychopharmacology of the endocannabinoids: far beyond anandamide.
    Pamplona FA; Takahashi RN
    J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
    Río CD; Millán E; García V; Appendino G; DeMesa J; Muñoz E
    Biochem Pharmacol; 2018 Nov; 157():122-133. PubMed ID: 30138623
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do cannabinoids have a role in cancer pain management?
    Farquhar-Smith WP
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):7-13. PubMed ID: 19262386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The endocannabinoid system and neuropathic pain.
    Maldonado R; Baños JE; Cabañero D
    Pain; 2016 Feb; 157 Suppl 1():S23-S32. PubMed ID: 26785153
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
    Di Marzo V; Piscitelli F; Mechoulam R
    Handb Exp Pharmacol; 2011; (203):75-104. PubMed ID: 21484568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.